Network of protein-protein interaction of phosphatidylinositol 4, 5-bisphosphate 5-phosphatase, related with Lowe syndrome
PDF (Español (España))

How to Cite

Baldiris-Avila, R., Acosta, N., Arzuza-Romero, A., & Vivas-Reyes, R. (2016). Network of protein-protein interaction of phosphatidylinositol 4, 5-bisphosphate 5-phosphatase, related with Lowe syndrome. Revista De La Academia Colombiana De Ciencias Exactas, Físicas Y Naturales, 40(157), 559–567. https://doi.org/10.18257/raccefyn.381

Downloads

Download data is not yet available.

Métricas Alternativas


Dimensions

Abstract

Lowe syndrome is a disease transmitted by sex-linked inheritance. That mainly affects males, and very occasionally women. It consists of a mutation in the gene OCRL1 that affects inositol phosphate metabolism, producing significant problems on the eye, nervous system and kidneys. A network of protein-protein interaction for the enzyme phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Cytoscape software version 3.3.0 was build, from the information provided by the KEGG database, PubMed, BioGrid, STRING, Uniprot data, 26 proteins were extracted related with OCRL. Based on a functional and topological analysis, was obtained ontological categories (GO) of greater significance are related mediated transport vesicles and signal transduction steps by small GTPases. On the other hand, topological parameters of the network were built, transitivity coefficient: 0.033, diameter: 5,0 centralization: 0.55. © 2016. Acad. Colomb. Cienc. Ex. Fis. Nat. All rights reserved.
https://doi.org/10.18257/raccefyn.381
PDF (Español (España))

References

Astle, M.V., Horan, K.A., Ooms, L.M., & Mitchell, C.A. (2007). The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors? Biochem. Soc. Symp. 161-181.

Attree, O., Olivos, I.M., Okabe, I., Bailey, L.C., Nelson, D.L., Lewis, R.A., McInnes, R.R., and Nussbaum, R.L. (1992). The Lowe’s oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5- phosphatase. Nature 358: 239-242.

Avendaño L., Aljama P., Arias M., Caramelo C., De lo Ríos J., Lamas S. (2009). Nefrología Clinica 3ra Ed. Editorial Medica Panamericana. Madrid. 638 pp.

Avery G., Fletcher MA., MacDonald MG. (2001). Neonatología: Fisiopatología y manejo del recién nacido 5 ED. Editorial Medica Panamericana. Madrid. 994 pp.

Bökenkamp A., Böckenhauer D., Cheong H., Hoppe B., Tasic V., Unwin R., Ludwig M. (2009). Dent-2 Disease: A Mild Variant of Lowe Syndrome. The Journal of Pediatrics. Vol 155. 94-99 pp.

Casillas N., Villar V., Lizárraga A. (2016). Síndrome de Lowe: reporte de caso. Revista Mexicana de Oftalmología.

Charnas LR., Bernardini I., Rader D., Hoeg J., Gahl WA. (1991). Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med. 324: 1318-1325.

Chatr-Aryamontri A, Breitkreutz BJ, Oughtred R, Boucher L, Heinicke S, Chen D, Stark C, Breitkreutz A, Kolas N, O’Donnell L, Reguly T, Nixon J, Ramage L, Winter A, Sellam A, Chang C, Hirschman J, Theesfeld C, Rust J, Livstone MS, Dolinski K, Tyers M. (2014). The BioGRID interaction database: 2015 update. Nucleic Acids Research.

Chen, S., Zhang, X., Chen, L., Tian, Q., & Jiang, W. (2014). Analysis of OCRL gene mutation in a male infant with Lowe syndrome. Zhonghua yi xue yi chuan xue za zhi Chinese journal of medical genetics, 31(2): 223-227.

Conduit A, Dyson J, Mitchell C. (2012). Inositol polyphosphate 5-phosphatases; new players in the regulation of cilia and ciliopathies. FEBS Letters. Vol 586. 2846-2857 pp.

Cortés V. & Villanueva C. (2015). Epidemiologia del glaucoma congenito en la Asociación para evitar la Ceguera en Mexico, revisión de 5 años. Revista Mexicana de Oftalmología. Vol 89. 150-153 pp.

EBSCO Industries. DynaMED Plus. [En línea]. Consultado: enero de 2016. Disponible en http://www.dynamed.com/home/.

Elseiver B.V. ScienceDirect. [En línea]. Consultado: enero de 2016. Disponible en http://www.sciencedirect.com/

Li, F., Yue, Z., Xu, T., Chen, M., Zhong, L., Liu, T., Jing X., Deng J., Hu B., Liu Y., Wang, H. (2016). Dent Disease in Chinese Children and Findings from Heterozygous Mothers: Phenotypic Heterogeneity, Fetal Growth, and 10 Novel Mutations. The Journal of pediatrics.

Hoopes, R.R., Jr., Shrimpton, A.E., Knohl, S.J., Hueber, P., Hoppe, B., Matyus, J., Simckes, A., Tasic, V., Toenshoff, B., Suchy, S.F., et al. (2005). Dent Disease with mutations in OCRL1. Am. J. Hum. Genet. 76: 260-267.

Hou, X., Hagemann, N., Schoebel, S., Blankenfeldt, W., Goody, R. S., Erdmann, K. S., & Itzen, A. (2011). A structural basis for Lowe syndrome caused by mutations in the Rabbinding domain of OCRL1. The EMBO journal, 30 (8):1659-1670.

Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40 (Database issue):D109-14.

Krauß, M., & Haucke, V. (2007). Phosphoinositide‐ etabolizing enzymes at the interface between membrane traffic and cell signalling. EMBO reports, 8 (3): 241-246.

Kornfeld M; Synder RD; MacGee J; Russell D; Appenzeller O. (1975). The Oculo-Cerebral-Renal Syndrome of Lowe Neuromuscular Components. Arch Neurol. 32 (2): 103-107.

Lemmon M. (2007). Pleckstrin homology (PH) domains and phosphoinositides. Biochemical Society Symposia. 81-93 pp.

Lin, T., Orrison, B. M., Suchy, S. F., Lewis, R. A., & Nussbaum, R. L. (1998). Mutations Are Not Uniformly Distributed throughout theOCRL1Gene in Lowe Syndrome Patients. Molecular genetics and metabolism, 64 (1): 58-61.

Mao, Y.; Balkin, D. M.; Zoncu, R.; Erdmann, K. S.; Tomasini, L.; Hu, F.; Jin, M. M.; Hodsdon, M. E. & De Camilli, P. (2009). A PH domain within OCRL bridges clathrinmediated membrane trafficking to phosphoinositide metabolism. The EMBO Journal, 28 (13): 1831-1842.

Madhivanan, K., Mukherjee, D., & Aguilar, R. C. (2012). Lowe syndrome: between primary cilia assembly and Rac1-mediated membrane remodeling. Communicative & integrative biology, 5 (6): 641-644.

Madhivanan, K., & Aguilar, R. C. (2014). Ciliopathies: the trafficking connection. Traffic, 15 (10): 1031-1056. Madhivanan, K., Ramadesikan, S., & Aguilar, R. C. (2015).

Chapter Seven-Role of Ocrl1 in Primary Cilia Assembly. International review of cell and molecular biology, 317: 331-347.

McCrea, H. J., Paradise, S., Tomasini, L., Addis, M., Melis, M. A., De Matteis, M. A., & De Camilli, P. (2008). All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding. Biochemical and biophysical research communications, 369 (2): 493-499.

Montjean, R., Aoidi, R., Desbois, P., Rucci, J., Trichet, M., Salomon, R., Rendu J, Fauré J, Lunardi J, Gacon G, Billuart P, Dorseuil O. (2014). OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5Bindependent phenotypic variability relatively to Lowe syndrome cells. Human molecular genetics, ddu514.

Fejerman, F. Á., & Fernández Alvarez, E. (1988). Neurología pediátrica Ed.Médica Panamericana.

Muthappa A., Nazreen K., Al-kindi S. (2015). Duplication 1q as primary and 3q in (3;13) as secondary aberration in Fanconi anemia: Implications and literature review. Acta Haematologica Polonica. Vol 46. 368-371 pp.

National Center for Biotechnology Information. PubMed. [En linea]. Consultado: enero de 2016. Disponible en http://www.ncbi.nlm.nih.gov/pubmed/

Núñez A., Aránguiz J., Kattan J., Escobar R. (2008). Síndrome hipotónico del recién nacido. Revista Chilena de Pediatría. Vol 79. 146-151 pp.

Nussbaum RL; Suchy SF. (2001). The oculocerebrorenal syndrome of Lowe (Lowe syndrome). The Metabolic and Molecular Bases of Inherited Disease Volume Ch 252. 8th edition. Edited by: Scriver CR, Beadet AL, Sly WS, Valle D. Mc-Graw Hill. New York. 6257-6266 pp.

Ooms, L.M., Horan, K.A., Rahman, P., Seaton, G., Gurung, R., Kethesparan, D.S., and Mitchell, C.A. (2009). The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem. J. 419: 29-49.

Pirruccello M & De Camilli P. (2012). Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochemical Sciences, Cell press. Vol 37. 134-143 pp.

Sadava D. (2009). Vida: Ciencia de la Biología octava edición. Editorial Médica Panamericana. Buenos Aires. 276 pp.

Santucci L., Candiano G., Anglani F., Bruschi M., Tosetto E., Cremasco D., Murer L., D`Ambrosio C., Scaloni A., Petretto A., Caridi G., Rossi R., Bonanni A., Ghiggeri

G. (2016). Urine proteome analysis in Dent’s disease shows high selective changes potentially involved in chronic renal damage. Journal of Proteomics, 130: 26-32.

Satir, P., & Christensen, S. T. (2008). Structure and function of mammalian cilia. Histochemistry and cell biology, 129 (6):687-693.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research; 13 (11): 2498-504.

Shrimpton A.E, Hoopes, Jr. R.R, Knohl S.J, Hueber P, Reed A.A, Christie P.T, Igarashi T, Lee P, Lehman A, White C, Milford D.V, Sanchez M.R, Unwin R, Wrong O.M, Thakker R.V, Scheinman S.J. (2009). OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiology, 112 (2): p27-p36.

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, Von Mering C. (2015). STRING v10:Protein-Portein interaction networks, integrated over the tree of life. Nucleic Acids Res. Jan;43. (Database issue): D447-52.

Taleisnik S. (2006). Receptores Celulares y la transducción de señales 1ª ed. Encuentro Grupo Editor. Córdoba. 127-132.

Trésaugues, L., Silvander, C., Flodin, S., Welin, M., Nyman, T., Gräslund, S., Hammarströn, M., Berglund, H. & Nordlund, P. (2014). Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases. Structure, 22 (5): 744-755.

Thompson J. & Lakhani N. (2015). Cataracts. Primary Care:Clinics in Office Practice. Vol. 42. 409-423 pp.

Uniprot, C. (2010). Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Research 39 (Database issue): D214–D219.

Vicinanza, M., D’Angelo, G., Di Campli, A., & De Matteis, M. A. (2008). Function and dysfunction of the PI system in membrane trafficking. The EMBO journal, 27 (19): 2457-2470.

Yepes R., Virgili C., Povedano M., Guerrero M., Villabona C. (2015). Kennedy`s disease and partial androgen insensitivity síndrome. Report of 4 cases and literatura review. Endocrinología y Nutrición. Vol 62. 224-230 pp.

Declaration of originality and transfer author's rights

The authors declare:

  1. The published data and reference materials have been duly identified with their respective credits and have been included in the bibliographic notes and citations that have been so identified and that should it be required, I have all releases and permissions from any copyrighted material. 
  2. All material presented is free from any copyright and that I accept full legal responsibility for any legal claims relating to copyrighted intellectual property, fully exonerating from responsibility the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.
  3. This work is unpublished and will not be sent to any other journal while waiting for the editorial decision of this journal. I declare that there is no conflict of interest in this manuscript.
  4. In case of publication of this article, all author´s rights are transferred to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, and so cannot be reproduced in any form without the express permission of it.
  5. By means of this document, if the article is accepted for publication by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, the Revista assumes the right to edit and publish the articles in national and international indices or data bases for academic and scientific use in paper, electronic, CD-ROM, internet form either of the complete text or any other known form known or to be known and non-commercial, respecting the rights of the authors.

Transfer of author rights

In case the article is approved for publication, the main author in representation of himself and his co-authors or the main author and his co-authors must cede the author rights of the corresponding article to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, except in the following cases:

The authors and co-authors will retain the right to revise, adapt, prepare derived works, oral presentations, and distribution to some colleagues of reprints of their own published work, if the corresponding credit is given to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales. It is also permissible to publish the title of the work, summary, tables, and figures of the work in the corresponding web sites of the authors or their employers, also giving credit to the Revista.

If the work has been realized under contract, the author’s employer has the right to revise, adapt, prepare derivative works, reproduce, or distribute in hard copy the published work, in a secure manner and for the exclusive use of his employees.

If the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales were approached for permission by a third party for using, printing, or publishing specifically articles already published, the Revista must obtain the express permission of the author and co-authors of the work or of the employer except for use in classrooms, libraries, or reprinted in a collective work. The Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales reserves the possible use in its front cover of figures submitted with the manuscripts.

No other right, other than the author’s right, can be claimed by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.